Federal regulators will no longer require patients to provide blood tests before receiving the drug from pharmacies.

The symptoms of schizophrenia vary greatly from person to person. A new study appearing in the American Journal of Psychiatry ...

Patients will no longer need to provide blood test results before they can get clozapine prescriptions filled, according to ...

The subtleties involved here reflect the fact that the brain’s dizzying complexity means it’s rarely possible to draw simple ...

Study finds the biological heterogeneity of schizophrenia is reflected in structural irregularities of the brain as well as functional abnormalities.

The symptoms of schizophrenia vary greatly from person to person. A new study shows how these differences manifest themselves in the structure of the ...

Feb. 26, 2025 — The symptoms of schizophrenia vary greatly from person to person. A new study shows how these differences manifest themselves in the structure of the ... Genetic Risk of ...

Researchers analyzed thousands of brain scans to uncover how schizophrenia varies at a structural level. While some brain ...

(HealthDay News) — The U.S. Food and Drug Administration has removed one hurdle faced by patients with schizophrenia when filling prescriptions for the antipsychotic medication clozapine.

A new international study reveals that schizophrenia manifests differently in the brain, reflecting the wide range of symptoms among patients.

A research study has analyzed the relation between the genetic risk of having schizophrenia and mild subclinical traits in people of the general population. According to the study, the way the genetic ...

The company is leaning on its subcutaneous technology to deliver long-acting options that could prevent patients from cycling through drugs.